Kuros Biosciences (CSBTF) Q2 2023 Earnings Report
CSBTF Q2 2023 EPS Results
- Actual EPS
- -$0.17
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.14
CSBTF Q2 2023 Revenue Results
- Actual Revenue
- $15.55M
- Expected Revenue
- $10.86M
- Beat/Miss
- Beat by +$4.69M
- YoY Revenue Growth
- +23.40%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/09/2023
- Time
- Before Open
- Conference Call
- Wednesday, August 9, 2023
CSBTF Upcoming Earnings
Kuros Biosciences's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CSBTF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | 0.10- | 0.11 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | 0.070.07 | -0.04 | 262.22% (+0.12) | |
| Mar 10, 2026 | 2025 (Q4) | 0.000.11 | -0.13 | 184.55% (+0.25) | |
| Aug 14, 2025 | 2025 (Q2) | ―-0.05 | -0.01 | -650.00% (-0.05) | |
| Mar 11, 2025 | 2024 (Q4) | ―-0.13 | -0.29 | 53.59% (+0.15) | |
| Aug 08, 2024 | 2024 (Q2) | ―-0.01 | -0.17 | 95.65% (+0.16) | |
| Mar 13, 2024 | 2023 (Q4) | ―-0.29 | -0.38 | 25.47% (+0.10) | |
| Aug 09, 2023 | 2023 (Q2) | ―-0.17 | -0.14 | -22.12% (-0.03) | |
| Mar 15, 2023 | 2022 (Q4) | ―-0.38 | -0.27 | -40.09% (-0.11) | |
| Aug 09, 2022 | 2022 (Q2) | ―-0.14 | 0 | -3666.67% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
